SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Evolus, Inc. (EOLS) (CIK 0001570562) (EOLS) — Jul 11, 2018

Evolus, Inc. (EOLS) (CIK 0001570562)
Date: July 11, 2018 · CIK: 0001570562 · Accession: 0000000000-18-021245

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
July 11, 2018
Author
David Moatazedi
Form
UPLOAD
Company
Evolus, Inc. (EOLS) (CIK 0001570562)

Letter

July 11, 2018 David Moatazedi President and Chief Executive Officer Evolus, Inc. 17901 Von Karman Avenue, Suite 150 Irvine, CA 92614 Re:Evolus, Inc. Draft Registration Statement on Form S-1 Submitted July 2, 2018 CIK No. 0001570562 Dear Mr. Moatazedi: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Michael A. Hedge, Esq.

Show Raw Text
July 11, 2018
David Moatazedi
President and Chief Executive Officer
Evolus, Inc.
17901 Von Karman Avenue, Suite 150
Irvine, CA 92614
Re:Evolus, Inc.
Draft Registration Statement on Form S-1
Submitted July 2, 2018
CIK No. 0001570562
Dear Mr. Moatazedi:
            This is to advise you that we do not intend to review your registration statement.
            We request that you publicly file your registration statement no later than 48 hours prior
to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            Please contact Christine Westbrook at 202-551-5019 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Michael A. Hedge, Esq.